Nanning, Guangxi municipal government from Germany to introduce regenerative medicine and the establishment of professional stem cell transplantation medical institutions - Nanning regenerative cell transplantation treatment center. Under the leadership of Dr. Thomas Lin, director of the treatment center, the center is dedicated to the regenerative cell transplantation. Under the leadership of German medical director Thomas Lin, the treatment center is committed to the promotion and application of regenerative medicine in China, and has cured a number of difficult and critical patients, and achieved significant medical results. The Center is the first in the world to pioneer autologous stem cell/islet transplantation for the treatment of diabetes mellitus, which has a good therapeutic effect on young and middle-aged type 2 diabetes mellitus patients; transcoronary autologous stem cell transplantation for the treatment of ischemic heart disease, ischemic cardiomyopathy, hypertension heart disease and cardiac failure has a very good therapeutic effect; treatment of paraplegia in spinal cord injuries has a good rehabilitative effect; the remission of malignant hematologic diseases, the early stage and the intermediate stage Treatment of senile dementia and Parkinson's disease as well as cerebral hemorrhage and cerebral infarction, cerebral injury, cerebellar injury, brain stem injury, and other neurological diseases and injuries treatment have significant therapeutic effects. Nanning Regenerative Cell Transplantation Treatment Center has a number of medical experts, as well as a number of chief physicians and deputy chief physicians, as well as attending physicians, supervising licensed pharmacists, more than 20 supervising nurses, nurse practitioners and nurses, equipped with modern and advanced medical equipment.
Nanning Regenerative Cell Transplantation Treatment Center has the advantages of stem cell medical biotechnology:
* Nanning Regenerative Cell Transplantation Treatment Center has the autologous/allogeneic stem cell technology created by Dr. Thomas Lin, a German medical doctor. The Nanning Regenerative Cell Transplantation Treatment Center possesses the proprietary technology of autologous/allogeneic stem cell extraction and purification created by Dr. Thomas Lin of Germany, which can not only extract and purify enough stem cells to treat leukemia in one patient or healthy volunteer, but also extract and purify enough stem cells to regenerate and reconstructive repair to treat degenerative, necrotic, and traumatic diseases;
* The treatment center possesses a variety of different adult stem cells created by Dr. Thomas Lin of Germany, which are used in the treatment of leukemia, necrosis and traumatization. The treatment center has the proprietary technology created by Dr. Thomas Lin, M.D., Germany, to transform different adult stem cells into each other, which can meet the clinical needs of some diseases;
* The treatment center has the proprietary technology created by Dr. Thomas Lin, M.D., Germany, to convert adult stem cells into stem cells. The treatment center has the proprietary technology of stem cell differentiation and induction to various specific body cells created by Dr. Thomas Lin, a German medical doctor. For example, stem cells to pancreatic islet cell differentiation induction technology, stem cells to neural cell differentiation induction technology, stem cells to cardiomyocyte differentiation induction technology, stem cells to vascular endothelial cell differentiation induction technology, stem cells to osteoblast differentiation induction technology, etc.
The treatment center has the original proprietary technology created by Dr. Thomas Lin.
Advantages of Autologous Stem Cell Regeneration and Reconstruction Therapy
* Stem cells from the body, no transplantation rejection, efficacy is significant, stable, safe and reliable.
* There is no potential danger of infectious disease infection caused by allogeneic stem cell transplantation.
* The treatment method of autologous stem cell transplantation also does not need to search for donors, does not need to match, does not need to wait for the source of allogeneic donor stem cells, and does not need to invest a lot of money, manpower, and material resources to set up a stem cell bank or bone marrow bank, so that the patient can be collected and transplanted as he/she arrives, which is convenient and economical, and the patient can be treated in a timely manner.